ASX:BIT Biotron (BIT) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Biotron Stock (ASX:BIT) 30 days 90 days 365 days Advanced Chart Ad InvestorPlaceWhat This Post-Election Shift Means for Your InvestmentsThe election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. Get Biotron alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume1.03 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield5.08%Price TargetN/AConsensus RatingN/A Company OverviewBiotron Limited, a biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia. Its lead antiviral drug is BIT225, which is in Phase II clinical trials for the treatment of SARS-CoV-2, HIV-1, and hepatitis C virus infections. The company was incorporated in 1999 and is based in Sydney, Australia.Read More… What This Post-Election Shift Means for Your Investments (Ad)The election may be over, but its impact on financial markets is only beginning. New trends are emerging, bringing both challenges and opportunities for investors. Many of these changes are flying under the radar, yet they have the potential to reshape the financial landscape for years to come. Understanding how these shifts could affect your wealth—and what steps to take—has never been more important.Click here now to watch the full briefing and prepare for what's next. Receive BIT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biotron and its competitors with MarketBeat's FREE daily newsletter. Email Address BIT Stock News HeadlinesBiotron Limited Issues New Shares on ASXNovember 19 at 3:52 AM | markets.businessinsider.comBiotron Limited Updates Disclosure Policy Amid ASX ConcernsNovember 15, 2024 | markets.businessinsider.comWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who understand the shifts ahead, this could be the foundation for long-term wealth creation. In this exclusive briefing, I'll show you exactly how to prepare for the challenges and opportunities ahead. You'll learn actionable strategies to protect your portfolio and position yourself for growth in the months and years to come.November 22, 2024 | InvestorPlace (Ad)Biotron Limited Announces New Securities Quotation on ASXNovember 12, 2024 | markets.businessinsider.comBiotron’s Mixed Trial Results and Future ProspectsOctober 30, 2024 | markets.businessinsider.comBiotron Limited Options Expiry ApproachesOctober 23, 2024 | markets.businessinsider.comBiotron Limited Releases 2024 Annual Report and AGM NoticeOctober 22, 2024 | markets.businessinsider.comGladiators – BBC micro:bit Live Lesson: Tuesday 15 October, 11:00October 9, 2024 | bbc.co.ukSee More Headlines BIT Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Biotron own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biotron investors own include TPG Co. Limited (TPM.AX) (TPM), Gemfields Group (GEM), Northern Star Resources (NST), Nokia Oyj (NOK), Mesoblast (MESO), MARA (MARA) and FYI Resources (FYI). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolASX:BIT CUSIPN/A CIKN/A Webwww.biotron.com.au Phone61 2 9805 0488FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,440,000.00 Net Margins-208.89% Pretax MarginN/A Return on Equity-234.68% Return on Assets-94.68% Debt Debt-to-Equity Ratio1.50 Current Ratio0.58 Quick Ratio2.32 Sales & Book Value Annual Sales$1.65 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow6.71 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares902,310,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.61 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report This page (ASX:BIT) was last updated on 11/22/2024 by MarketBeat.com Staff From Our Partners[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredCentral Bank Abandons USDYou know what doesn't care about elections? Gold. If you want to protect your savings & retirement from our...Desko Digital | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredWhat Comes Next Could Be a Once-in-a-Lifetime OpportunityA wave of technological and financial transformation is reshaping the investment landscape. For those who unde...InvestorPlace | SponsoredAre Your Retirement Savings Really Safe?What They Don’t Want You to Know About Your 401(k)The 2008-2010 crisis wiped out almost 50% of the value of retirement funds. If you knew it was coming, wouldn'...American Hartford Gold | SponsoredNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biotron Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Biotron With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.